(Q41109695)

26 September 2017

1 reference

title

Diagnosis and therapy of cholestatic liver disease (English)

1 reference

26 September 2017

Pasha TM

1

1 reference

26 September 2017

Lindor KD

series ordinal

2

1 reference

26 September 2017

publication date

1 September 1996

1 reference

Medical Clinics of North America

26 September 2017

published in

1 reference

26 September 2017

volume

80

1 reference

26 September 2017

issue

5

1 reference

26 September 2017

page(s)

995-1019

1 reference

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Criteria of drug-induced liver disorders. Report of an international consensus meeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Evaluation of colchicine therapy in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Gallbladder disease in patients with primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Association of primary sclerosing cholangitis with HLA-B8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Rheumatic disorders in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Drug-induced prolonged cholestasis in adults: A histological semiquantitative study demonstrating progressive ductopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Current problems in diagnosis of biliary disease and cholestasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Prognosis in primary biliary cirrhosis: model for decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Portal bacteraemia in cases of ulcerative colitis submitted to colectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Natural history and prognostic variables in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Randomized trial of chlorambucil for primary biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

NIH conference: Primary biliary cirrhosis: a model autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Medical approaches to primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Pruritus associated with cholestasis. A review of pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Biochemical factors in alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Hepatobiliary complications of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Advances in primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary sclerosing cholangitis: findings on cholangiography and pancreatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Efficacy of liver transplantation in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Orthotopic liver transplantation for primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Prolonged postpartum course of intrahepatic cholestasis of pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Treatment of pruritus of primary biliary cirrhosis with rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Cholangiocarcinoma complicating primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Current concepts in diagnosis. Approach to the patient with cholestatic jaundice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

The Presentation and Diagnosis of 100 Patients with Primary Biliary Cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

Primary biliary cirrhosis, dark adaptometry, electro-oculography, and vitamin A state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970477-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70477-6

1 reference

26 September 2017

1 reference